There's a peculiar thing in the breastfeeding conversation: the recommendations are confident, but the studies are less so. WHO recommends breastfeeding to age 2 and beyond. AAP recommends exclusive breastfeeding for 6 months and continuing for at least a year, "as long as mutually desired." Both are reasonable; neither is what the data unambiguously shows.
The honest answer is: the strongest benefits show up in the first few months, with diminishing returns after that. Any amount of breastfeeding is associated with measurable benefit. There is no evidence-based reason to continue past whatever point works for the parent.
What's actually been shown — and how strongly
The PROBIT trial (Kramer 2001 JAMA, follow-ups through 2008 in The Lancet) is the largest randomized study of breastfeeding promotion. It found small but real benefits in early infections and modest cognitive differences (~3 IQ points) at age 6. The cognitive effect held up better than the immune effect.
A 2016 Cochrane review of breastfeeding duration found:
- Strong evidence for reduced gastrointestinal infections in the first 6 months
- Moderate evidence for reduced respiratory infections in the first year
- Modest evidence for reduced ear infections through 12 months
- Limited evidence for reduced obesity and type 2 diabetes risk later in life
- Little to no evidence for benefits added by breastfeeding past 12 months in well-resourced settings
Importantly: these are population-level effects. Your specific baby's health outcomes depend on dozens of factors. Breastfeeding moves the needle modestly across many of them.
Per-month benefit, roughly
Pulling the literature together, here's the rough shape:
- Months 0–3: largest single benefit window. The colostrum + early milk transfers passive immunity (IgA antibodies) that can't be replicated by formula.
- Months 3–6: continued infection-rate benefits, especially gastrointestinal. The 6-month exclusive recommendation is grounded here.
- Months 6–12: smaller incremental immune benefits. Solids cover growing nutritional needs that breast milk alone can't meet by ~9–12 months.
- Months 12–24: emotional/relational benefits and continued antibody transfer for any active infections. Population-level health benefits are small and inconsistent in the literature.
- Beyond 24 months: WHO's recommendation is grounded mostly in low-resource settings where weaning earlier introduces nutritional or infectious risk. In high-resource settings, the marginal health benefit is approximately zero — the relationship is the dominant value.
What about the things people claim?
Cognitive benefit: real but small (PROBIT found ~3 IQ points at age 6, with confidence intervals close to zero). Most observational studies overestimate this because of confounding with maternal education and SES.
Allergy prevention: weak. The 2019 AAP statement walked back earlier claims that breastfeeding prevents allergies — the evidence simply isn't there.
Bonding: real, but breastfeeding is one of many ways. Bottle-feeding parents bond fine; the bonding hormone (oxytocin) releases during feeding regardless of source.
Maternal benefits (faster postpartum weight loss, reduced breast/ovarian cancer risk): present but modest, and stronger with cumulative duration than with any specific milestone.
The honest framing
Any amount has value. Six months is the strongest duration target supported by data. Twelve months captures most of the remaining incremental benefit. Past that, it's a parental relationship choice — not a medical one. If breastfeeding is hurting your mental health, your sleep, or your ability to be present with your baby, the trade-off has tipped.
Combination feeding (breast + formula) is fine. Donor milk is fine. Pumped milk via bottle is fine. The data on outcomes shows much less variation by feeding method than the cultural conversation implies.